MGMT and glioblastoma: Moreover, it has been reported that GBM patients with O‐6‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation respond more favorably to cilengitide treatment than those with MGMT promoter unmethylation [17, 57] (NCT00689221).